113 related articles for article (PubMed ID: 15105386)
1. Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.
Eberhard J; Ståhl O; Giwercman Y; Cwikiel M; Cavallin-Ståhl E; Lundin KB; Flodgren P; Giwercman A
Hum Reprod; 2004 Jun; 19(6):1418-25. PubMed ID: 15105386
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment.
Bogefors K; Giwercman YL; Eberhard J; Stahl O; Cavallin-Stahl E; Cohn-Cedermark G; Arver S; Giwercman A
Asian J Androl; 2017; 19(5):538-542. PubMed ID: 27873769
[TBL] [Abstract][Full Text] [Related]
3. Paternity following treatment for testicular cancer.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O
J Natl Cancer Inst; 2005 Nov; 97(21):1580-8. PubMed ID: 16264178
[TBL] [Abstract][Full Text] [Related]
4. Associations between androgen receptor CAG repeat length and sperm morphology.
Milatiner D; Halle D; Huerta M; Margalioth EJ; Cohen Y; Ben-Chetrit A; Gal M; Mimoni T; Eldar-Geva T
Hum Reprod; 2004 Jun; 19(6):1426-30. PubMed ID: 15117901
[TBL] [Abstract][Full Text] [Related]
5. Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage.
Giwercman A; Lundin KB; Eberhard J; Ståhl O; Cwikiel M; Cavallin-Ståhl E; Giwercman YL
Eur J Cancer; 2004 Sep; 40(14):2152-8. PubMed ID: 15341991
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor gene CAG repeat length as a modifier of the association between persistent organohalogen pollutant exposure markers and semen characteristics.
Giwercman A; Rylander L; Rignell-Hydbom A; Jönsson BA; Pedersen HS; Ludwicki JK; Lesovoy V; Zvyezday V; Spano M; Manicardi GC; Bizzaro D; Bonefeld-Jørgensen EC; Toft G; Bonde JP; Giwercman C; Tiido T; Giwercman YL;
Pharmacogenet Genomics; 2007 Jun; 17(6):391-401. PubMed ID: 17502831
[TBL] [Abstract][Full Text] [Related]
7. Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.
Eberhard J; Ståhl O; Cohn-Cedermark G; Cavallin-Ståhl E; Giwercman Y; Rastkhani H; Rylander L; Eberhard-Gran M; Kvist U; Giwercman A
J Affect Disord; 2010 May; 122(3):260-6. PubMed ID: 19656574
[TBL] [Abstract][Full Text] [Related]
8. Gonadal function in men with testicular cancer.
Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
[TBL] [Abstract][Full Text] [Related]
9. Sperm DNA integrity in testicular cancer patients.
Ståhl O; Eberhard J; Jepson K; Spano M; Cwikiel M; Cavallin-Ståhl E; Giwercman A
Hum Reprod; 2006 Dec; 21(12):3199-205. PubMed ID: 16931803
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the androgen receptor gene in testicular cancer.
Garolla A; Ferlin A; Vinanzi C; Roverato A; Sotti G; Artibani W; Foresta C
Endocr Relat Cancer; 2005 Sep; 12(3):645-55. PubMed ID: 16172197
[TBL] [Abstract][Full Text] [Related]
11. Prediction of posttreatment spermatogenesis in patients with testicular cancer by flow cytometric sperm chromatin structure assay.
Fosså SD; De Angelis P; Kraggerud SM; Evenson D; Theodorsen L; Clausen OP
Cytometry; 1997 Aug; 30(4):192-6. PubMed ID: 9298838
[TBL] [Abstract][Full Text] [Related]
12. Semen quality before and after gonadotoxic treatment.
Bahadur G; Ozturk O; Muneer A; Wafa R; Ashraf A; Jaman N; Patel S; Oyede AW; Ralph DJ
Hum Reprod; 2005 Mar; 20(3):774-81. PubMed ID: 15689346
[TBL] [Abstract][Full Text] [Related]
13. Modifying effect of the AR gene trinucleotide repeats and SNPs in the AHR and AHRR genes on the association between persistent organohalogen pollutant exposure and human sperm Y:X ratio.
Tiido T; Rignell-Hydbom A; Jönsson BA; Rylander L; Giwercman A; Giwercman YL
Mol Hum Reprod; 2007 Apr; 13(4):223-9. PubMed ID: 17244640
[TBL] [Abstract][Full Text] [Related]
14. Length of androgen receptor-CAG repeats in fertile and infertile Egyptian men.
Badran WA; Fahmy I; Abdel-Megid WM; Elder K; Mansour R; Kent-First M
J Androl; 2009; 30(4):416-25. PubMed ID: 19168451
[TBL] [Abstract][Full Text] [Related]
15. Evidence for association of sex hormone-binding globulin and androgen receptor genes with semen quality.
Lazaros L; Xita N; Kaponis A; Zikopoulos K; Sofikitis N; Georgiou I
Andrologia; 2008 Jun; 40(3):186-91. PubMed ID: 18477206
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer.
Klotz L; Correia A; Zhang W
Prostate Cancer Prostatic Dis; 2005; 8(2):179-83. PubMed ID: 15809670
[TBL] [Abstract][Full Text] [Related]
17. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
[TBL] [Abstract][Full Text] [Related]
18. The impact of androgen receptor polymorphism and parental ethnicity on semen quality in young men from Latvia.
Erenpreiss J; Tsarev I; Giwercman A; Giwercman Y
Int J Androl; 2008 Sep; 31(5):477-82. PubMed ID: 17916185
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor gene GGN and CAG polymorphisms among severely oligozoospermic and azoospermic Swedish men.
Ruhayel Y; Lundin K; Giwercman Y; Halldén C; Willén M; Giwercman A
Hum Reprod; 2004 Sep; 19(9):2076-83. PubMed ID: 15229204
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the polymorphic CAG repeat length in the androgen receptor gene in patients with testicular germ cell cancer.
Rajpert-De Meyts E; Leffers H; Daugaard G; Andersen CB; Petersen PM; Hinrichsen J; Pedersen LG; Skakkebaek NE
Int J Cancer; 2002 Nov; 102(2):201-4. PubMed ID: 12385020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
